Summary by Futu AI
TIGERMED will hold its 2024 Shareholder Annual Meeting at 10:00 AM on May 30, 2025, at its headquarters in Hangzhou. The meeting will review 10 ordinary resolutions, including the 2024 annual report, profit distribution plan, financial results report, and 3 special resolutions regarding amendments to the company’s articles of association, Listed in Hong Kong issuance, and repurchase authorization. The meeting will be chaired by Chairman Ye Xiaoping, and all resolutions will be voted on.To ensure the eligibility of Shareholders to attend, the company will suspend the registration of Listed in Hong Kong Shareholders from May 27 to 30, 2025. Listed in Hong Kong Shareholders must complete the transfer registration by 4:30 PM on May 26, 2025. Ordinary resolutions require more than half of the voting rights to pass, while special resolutions require more than two-thirds of the voting rights to pass. Shareholders may appoint representatives to attend the meeting and vote, and the relevant authorization documents must be delivered to the registration office for Listed in Hong Kong shares 24 hours before the meeting.
